Australian medical cannabis firm to open Birmingham base
An Australian medical cannabis company is set to open a new UK operation in Birmingham. Sydney-based Cannim has struck a deal ...
MMJ Marijuana Waiting FDA Approved Huntington's Clinical Trials As RFK Jr.'s Push to Conduct Scientific Research
MMJ's innovative soft gelatin THC-CBD capsule, known as MMJ-002, is undergoing the rigorous FDA approval process to ...
greenmarketreport8d
MediPharm Labs scraps C$5.5M Ontario facility sale to Kensana Health
MediPharm will keep its Ontario cannabis facility after Kensana missed deal conditions; company pivots to international focus ...
Key FDA Marijuana Response, MMJ International Holdings Advances Cannabis-Derived Therapeutics for Huntington’s Disease
MMJ is currently engaged in litigation with the Drug Enforcement Administration (DEA). The company contends that the DEA has ...
C&EN26d
Semi-Synthesis of Dimeric Cannabidiol Derivatives and Evaluation of their Affinity at Neurological Targets
Department of Drug Discovery and Biomedical Sciences, College of Pharmacy, University of South Carolina, Columbia, South Carolina 29208, United States ...